| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/30/2013 | CA2479764C Hemiasterlin derivatives and uses thereof |
| 07/30/2013 | CA2430893C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 07/30/2013 | CA2276542C Novel peptide, a method for its preparation and a pharmaceutical composition containing the peptide |
| 07/25/2013 | WO2013110069A1 Glutamic acid-stabilized insulin analogues |
| 07/25/2013 | WO2013109675A2 Compositions and methods for treating cancer and inflammation-related diseases and conditions |
| 07/25/2013 | US20130190249 Therapeutically active compositions and their methods of use |
| 07/25/2013 | US20130190248 Substituted peptide analogs |
| 07/25/2013 | US20130189256 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| 07/25/2013 | DE102004038134B4 Multivalente Chelatoren zum Modifizieren und Organisieren von Zielmolekülen, Verfahren zu ihrer Herstellung sowie ihre Verwendung Multivalent chelators for modifying and organizing of target molecules, processes for their preparation and their use |
| 07/24/2013 | CN1853730B Modified cytokines for use in cancer therapy |
| 07/24/2013 | CN103214553A Method for extracting onion osteogenic peptide |
| 07/24/2013 | CN103214552A Synthesis and application of multi-site modified endomorphin-1 analogue |
| 07/24/2013 | CN102477069B Pro-Ala-Lys-Asp[OCH2(CH2)nCH3]-OCH2(CH2)nCH3, synthesizing method thereof, and application thereof as thrombolytic agent |
| 07/24/2013 | CN102477068B Amino acid derivative for preparing thrombus dissolving medicament, and preparation method and application thereof |
| 07/24/2013 | CN102286069B Method for primarily purifying glutathione fermentation liquid by precipitation and separation with organic solvent |
| 07/24/2013 | CN101928458B Preparation method of multifunctional nanometer composite particle constructed by modified polymine |
| 07/24/2013 | CN101503373B 2-amino-1-(4-nitro phenyl)-1-ethanol metalloid protease inhibitor, and preparation and use thereof |
| 07/23/2013 | US8492516 Zona pellucida binding peptides for species specific immunocontraception of animals |
| 07/23/2013 | US8492514 PRAME derived peptides and immunogenic compositions comprising these |
| 07/23/2013 | US8492347 Peptide for induction of immune tolerance as treatment for systemic lupus erythematosus |
| 07/23/2013 | US8492345 Cyclic peptide antitumor agents |
| 07/23/2013 | US8491910 Vaccine comprising AMB A 1 peptides for use in the treatment of ragweed allergy |
| 07/18/2013 | WO2013106819A2 Zinc-responsive peptides, and methods of use thereof |
| 07/18/2013 | WO2013106631A1 Processes for making hcv protease inhibitors |
| 07/18/2013 | US20130184629 Skin treatment devices and methods with pre-stressed configurations |
| 07/18/2013 | US20130184226 Modulations of protease activated receptors |
| 07/18/2013 | US20130184222 Therapeutically active compositions and their methods of use |
| 07/17/2013 | EP2614059A2 Methods for assaying enzyme activities |
| 07/17/2013 | CN1568329B Immunogenic peptide composition for the prevention and treatment of Alzheimer's disease |
| 07/17/2013 | CN103204905A Method for synthesizing tetra-glycylglycine |
| 07/17/2013 | CN103204904A Dasyatis akajei chondroprotein polypeptide capable of resisting prostate cancer, and preparation method and application thereof |
| 07/17/2013 | CN103204903A Hepatitis c inhibitor compounds |
| 07/17/2013 | CN103204902A Aqueous-phase synthesis of novel key intermediate used for preparation of bortezomib and application of key intermediate in synthesis of bortezomib |
| 07/17/2013 | CN103204901A Preparation method for bifunctional conjugate |
| 07/17/2013 | CN103204893A Method of improving oral absorption of carboxylic acids drugs by using Pep T1 targeting mimic-peptides diester prodrug technique |
| 07/17/2013 | CN103203010A Pharmaceutical Compositions Comprising Hepatitis C Inhibitor Compounds |
| 07/17/2013 | CN102558297B Endomorphin-1 analogue modified by alpha-alkenyl-beta-amino acid and composition and application thereof |
| 07/17/2013 | CN102533549B Nanogel scaffold material for culturing and desorbing type of cells and preparation method thereof |
| 07/17/2013 | CN102020699B Anti-platelet aggregation peptide and application thereof |
| 07/17/2013 | CN101928329B Tripeptide boric acid (ester) compound and preparation method and application thereof |
| 07/16/2013 | US8487077 Simplified one-pot synthesis of [18F]SFB for radiolabeling |
| 07/16/2013 | US8486989 Inhibitors of serine proteases, particularly HCV NS3-NS4A protease |
| 07/16/2013 | US8486955 Anti-cancer cyclopenta [g] quinazoline compounds |
| 07/16/2013 | CA2526007C Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 07/16/2013 | CA2496215C Template-fixed peptidomimetics with antibacterial activity |
| 07/11/2013 | US20130178429 Macrocyclic kinase inhibitors and uses thereof |
| 07/11/2013 | US20130178413 Hcv ns3 protease inhibitors |
| 07/11/2013 | US20130177531 Inhibitors of Serine Proteases |
| 07/10/2013 | EP2612865A2 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 07/10/2013 | EP2612857A1 Chemical synthesis and anti-tumor and anti-metastatic effects of dual functional conjugate |
| 07/10/2013 | EP2612856A2 Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
| 07/10/2013 | EP2611904A2 Culture medium for eukaryotic cells |
| 07/10/2013 | EP2611822A2 Compositions for labeling nerves and methods of use |
| 07/10/2013 | EP2611797A2 Quinoline or quinazoline derivatives with apoptosis inducing activity on cells |
| 07/10/2013 | CN103201282A Dermatopontin-activating peptides and cosmetic compositions including same |
| 07/10/2013 | CN103193864A Delta crystalline form of the arginine salt of perindopril, a process for its preparation, and pharmaceutical compositions containing it |
| 07/10/2013 | CN103193863A Process for the preparation of perindopril L-arginine salt |
| 07/10/2013 | CN103191410A Treatment of T-cell mediated diseases |
| 07/10/2013 | CN103191409A Treatment of T-cell mediated diseases |
| 07/10/2013 | CN102432670B Silkworm chrysalis protein source dipeptide SS and application thereof |
| 07/10/2013 | CN102329371B Method for separating single stereoisomer of Argatroban and polymorphic substance |
| 07/09/2013 | US8481494 Compounds for the treatment of diseases related to protein misfolding |
| 07/09/2013 | US8481485 Insulin analogs |
| 07/09/2013 | US8481003 Anti-CD74 immunoconjugates and methods |
| 07/09/2013 | CA2565678C Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof |
| 07/09/2013 | CA2556917C Process for preparing macrocyclic compounds |
| 07/05/2013 | CA2801089A1 Preparation process for l-arginine perindopril salt |
| 07/05/2013 | CA2800946A1 Crystal delta form of arginine perindopril salt, its preparation process and the pharmaceutical compounds containing same |
| 07/04/2013 | WO2013098191A1 Dipeptide comprising a non-proteogenic amino acid |
| 07/04/2013 | WO2013057736A3 Preparation of eptifibatide peptide |
| 07/04/2013 | US20130172273 Cyclotetrapeptides with pro-angiogenic properties |
| 07/04/2013 | US20130172264 Inhibitors of iap |
| 07/04/2013 | US20130172242 Growth hormone secretatogue receptor antagonists and uses thereof |
| 07/04/2013 | US20130172232 Cysteine protease inhibitors |
| 07/04/2013 | US20130171085 Amino acid derivatives; compositions containing them; use as agents for treating human perspiration |
| 07/04/2013 | US20130171074 Targeting compounds |
| 07/04/2013 | US20130171069 Neurotoxic target for amylospheroid, method and material for reducing the neurotoxicity of amylospheroid, and use thereof |
| 07/04/2013 | CA2861000A1 Dipeptide comprising a non-proteogenic amino acid |
| 07/03/2013 | CN103189384A Diketopiperazine forming dipeptidyl linker |
| 07/03/2013 | CN103183726A Peptides derived from human BPLP protein, polynucleotides coding for said peptides and antibodies directed against said peptides |
| 07/03/2013 | CN103183724A Preparation method of docetaxel conjugate |
| 07/03/2013 | CN103183723A 新颖的尿苷肽类抗生素及其用途 Uridine novel peptide antibiotics and their use |
| 07/03/2013 | CN103183722A Glyoxalase I inhibitor, preparation method and medical application thereof |
| 07/03/2013 | CN102329372B Method for preparing peptide aldehyde |
| 07/03/2013 | CN102241737B Endomorphin-1 analogs, synthesis thereof and application of endomorphin-1 analogs in preparation of analgesic medicines |
| 07/02/2013 | US8476306 Urokinase inhibitors, production and use thereof |
| 06/27/2013 | WO2013096755A1 Proteolytically resistant hydrogen bond surrogate helices |
| 06/27/2013 | US20130165392 Hepatocyte growth factor mimics as therapeutic agents |
| 06/27/2013 | US20130165390 Boronate ester compounds and pharmaceutical compositions thereof |
| 06/27/2013 | US20130165386 Quinoline or quinazoline derivatives with apoptosis inducing activity on cells |
| 06/27/2013 | US20130165333 Methods and Systems for Preparing Irreversible Inhibitors of Protein Tyrosine Phosphatases |
| 06/26/2013 | EP2607373A1 Liquid phase synthesis of self-assembling peptides to be linked to polymers or to other bioactive and/or self-assembling peptides |
| 06/26/2013 | CN103180335A Process for the manufacture of degarelix and its intermediates |
| 06/26/2013 | CN103179862A Chromobacterium bioactive compositions and metabolites |
| 06/26/2013 | CN103172700A Pcr hot start by magnesium sequestration |
| 06/26/2013 | CN103172699A 17beta-amino-11alpha-hydroxy-androsta-1,4-diene-3-ketone modified RGD tetrapeptide as well as synthesis and medical application thereof |
| 06/26/2013 | CN103172698A Antihypertensive polypeptides |
| 06/26/2013 | CN103172697A Process for preparing macrocyclic compounds |
| 06/26/2013 | CN103172696A Preparation method of perindopril arginine salt of gamma-crystal form |
| 06/26/2013 | CN103172695A Preparation method of glycyl-tyrosine |